Endocrine Considerations in Anesthesia - PowerPoint PPT Presentation

1 / 73
About This Presentation
Title:

Endocrine Considerations in Anesthesia

Description:

Thyrotropin (TSH) produced in anterior Pituitary gland ... Carpal tunnel syndrome. Stiff joint syndrome. Scleredema. Hyperalgesia. Autonomic Neuropathy ... – PowerPoint PPT presentation

Number of Views:1236
Avg rating:3.0/5.0
Slides: 74
Provided by: kum77
Category:

less

Transcript and Presenter's Notes

Title: Endocrine Considerations in Anesthesia


1
Endocrine Considerationsin Anesthesia
  • Thyroid
  • Diabetes
  • Adrenal Gland
  • Liver

2
Thyroidism
3
Thyroid Gland Hormones
  • Thyroid Hormones
  • Thyroxine (T4)
  • Triiodothyronine (T3)
  • A. Major regulators of cellular metabolic
    processes
  • B. Essential for neurological and cardiopulmonary
    function

4
Thyroid Gland Hormones
  • Thyrotropin (TSH) produced in anterior Pituitary
    gland
  • TSH secretion regulated by hypothalamus hormone
    thyrotropin-releasing hormone (TRH)
  • (T4) (T3) regulation by TRH TSH balance

5
Thyroid Gland Considerationsin Anesthesia
  • Cardiovascular manifestations
  • Heat regulation
  • Metabolism
  • Oxygen consumption

6
Thyroid Gland Considerationsin Anesthesia
  • Thyroid hormones directly affect tissue responses
    to sympathetic stimuli
  • Beta-adrenergic ? by thyroid hormone
  • Alpha-adrenergic ? by thyroid hormone

7
Hyperthyroidism
  • 1. Graves disease 20-40 y/o
  • Predominantly female
  • Opthalmopathy
  • Dermopathy
  • Club fingers
  • 2. Thyroiditis

8
Hyperthyroidism
  • 3. Hashimoto
  • (usually hypo but sometimes hyper)
  • 4. Adenomas
  • 5. Carcinoma
  • 6. Amiodarone drug induced
  • (rich in iodine ?thyrotoxicosis)

9
Hyperthyroidism Symptoms
  • Heat intolerance
  • Nervous
  • Weight loss
  • Tachycardia
  • Diarrhea

10
Tests of Thyroid Gland FunctionLaboratory
Determinations
  • Total plasma thyroxine (T4)
  • Detects gt 90 of hyperthyroid patients
  • Resin triiodothyronine uptake (RT3U)
  • Clarifies if T4 changes are due to thyroid
    dysfunction or alterations in T4 - binding
    globulin

11
Tests of Thyroid Gland FunctionLaboratory
Determinations
  • Total plasma triiodothyronine (T3)
  • Confirms diagnosis of hyperthyroidism
  • Thyroid stimulating hormone (TSH)
  • Confirms diagnosis of primary hypothyroidism

12
Tests of Thyroid Gland Function
  • Thyroid scan
  • Demonstrates iodide-concentrating
  • of the capacity of thyroid gland
  • Ultrasonography
  • Distinguishes between cystic and solid nodules
  • Antibodies
  • Distinguishes Hashimotos thyroiditis from
    cancer

13
Differential Diagnosis of Thyroid Gland
Dysfunction
  • T4 RT3U T3 TSH
  • Hyperthyroidism Incr. Incr. Incr.
    Decr
  • Hypothyroidism (P) Decr. Decr. Decr. Incr.
  • Hypothyroidism (S) Decr. Decr. Decr.
    Decr.
  • Pregnancy Incr. Decr. Normal
    Normal

14
Hyperthyroidism Symptoms
  • Anxiety
  • Heat intolerance
  • Fatigue
  • Skeletal muscle weakness

15
Hyperthyroidism
  • Goiter
  • Tachycardia
  • Atrial fibrillation
  • Tremor
  • Eye signs (proptosis)
  • Weight loss

16
HyperthyroidismTreatment
  • Antithyroid drugs
  • (propylthiouracil, methimazole)
  • Propranolol
  • Radioactive iodine

17
Subtotal ThyroidectomyComplications
  • Airway obstruction
  • Hypoparathyroidism

18
Subtotal Thyroidectomy Intraoperative Hazards
  • Circulatory disturbances
  • Thyroid storm
  • Cooled saline infusion
  • Esmolol

19
Subtotal Thyroidectomy Preoperative Measures
  • Normalize thyroid function
  • Utilize beta sympathetic blockers
  • Avoid anticholinergic drugs
  • Evaluate upper airway
  • (computed tomography)

20
HypothyroidismSymptoms Signs
  • Lethargy
  • Intolerance to cold
  • Bradycardia
  • Peripheral vasoconstriction
  • Adrenocortical atrophy
  • Hyponatremia

21
HypothyroidismAdverse Responses
  • Sensitivity to depressant drugs (opioids)
  • Hypodynamic circulation
  • Slowed metabolism (drugs)
  • Impaired ventilatory responses

22
Hypothyroidism Anesthetic Management
  • Preoperative supplemental hydrocortisone
  • Induction ketamine
  • Maintenance ultrashort acting drugs
  • Postoperative defer extubation until patient
  • is responsive and normothermic

23
Parathyroid
24
Parathyroid Gland Dysfunction
  • Disturbance of calcium levels
  • Muscle weakness
  • Polyuria and polydipsia
  • Abdominal pain, vomiting
  • Somnolence, psychosis
  • Insensitivity to pain

25
Hypercalcemia Signs
  • Renal
  • Decreased GFR, stone formation
  • Cardiac
  • Hypertension, prolonged P-R, short Q-T
  • Gastrointestinal
  • Peptic ulcer, pancreatitis
  • Skeletal
  • Bone demineralization
  • Ocular
  • Band keratopathy, conjunctivitis

26
Hypocalcemia
  • Acute symptoms and signs
  • Perioral paresthesias
  • Restlessness
  • Neuromuscular irritability (positive Chvostek or
  • Trousseau sign, inspiratory stridor)
  • Chronic symptoms and signs (renal failure)
  • Fatigue, muscle weakness
  • Prolonged Q-T interval

27
Diabetes
28
Diabetes Mellitus
  • Metabolic Changes IDDM NIDDM
  • Nutrition Thin Obese
  • Blood glucose Variable Stable
  • Ketoacidosis Common Uncommon
  • Requires insulin Yes Not always

29
Diabetes MellitusInsulin-Dependent vs.
Non-Insulin Dependent
  • Age of onset IDDM lt 16 y/o Onset abrupt
  • (Juvenile Diabetes)
  • Age of onset NIDDM gt35 y/o Gradual onset

30
Diabetes Mellitus
  • Manifestations
  • Polyphagia
  • Polydipsia
  • Polyuria

31
Diabetes Mellitus
  • Ketoacidosis
  • Autonomic neuropathy
  • Blood vessel pathology
  • Micro/macroangiopathy
  • Retinopathy
  • Atherosclerosis
  • Nephropathy
  • Cardiomyopathy

32
Diabetes MellitusOther Pathologic Changes
  • Carpal tunnel syndrome
  • Stiff joint syndrome
  • Scleredema
  • Hyperalgesia

33
Autonomic Neuropathy
  • Orthostatic hypotension
  • Resting tachycardia
  • Gastroparesis(vomiting,diarrhea)
  • Impotence
  • Cardiac dysrhythmias
  • Asymptomatic hypoglycemia
  • Sudden death syndrome

34
Preoperative Insulin Traditional Approach
  • Give 1/4 to 1/2 the daily dose of
    intermediate-acting insulin subcutaneously
  • Add 1/2 unit of intermediate-acting insulin for
    each unit of insulin prescribed
  • Start IV glucose 5-10 g/h

35
Preoperative Insulin Continuous IV Infusion
  • Place 50 U. Regular Insulin in 1000 ml NS
  • Give 10 ml/h
  • Measure blood glucose q.h.
  • Adjust infusion rate to keep glucose level at
  • 120-180 mg/dl
  • Turn infusion off for 30 min if glucose level
    falls below 80 mg/dl
  • Provide sufficient glucose (5-10g/h) and
    potassium (2-4 mEq/h)

36
Hyperosmolar HyperglycemicNonketotic Coma
  • Hyperosmolarity
  • Hyperglycemia
  • Normal pH
  • Osmotic diuresis (hypokalemia)
  • Hypovolemia (hemoconcentration)

37
Adrenal Gland
38
HyperadrenocorticismCushings Disease
  • Hypertension
  • Hypokalemia
  • Hyperglycemia
  • Muscle weakness
  • Osteoporosis
  • Obesity (cushingoid habitus)
  • Poor wound healing
  • Susceptibility to infection

39
HypoadrenocorticismAddisons Disease
  • Weight loss
  • Muscle weakness
  • Hyperpigmentation
  • Hypotension
  • Hyperkalemia
  • Hypoglycemia

40
Hyperaldosteronism Conns Syndrome
  • Hypertension
  • Hypokalemic metabolic alkalosis
  • Muscle weakness
  • Treatment 1.Supplemental potassium,
  • 2. Spironolactone

41
Pheochromocytoma(Catecholamine - Secreting Tumor)
  • Signs symptoms
  • diaphoresis, tachycardia, headache
  • Diagnosis
  • paroxysmal hypertension
  • localization by computed tomography
  • urinary excretion of catecholamine metabolites
    (vanillylmandelic acid)
  • Treatment prior to surgery
  • alpha beta sympathetic blockade
  • (phentolamine, dibenzyline, labetalol)

42
Pheochromocytoma Anesthetic Management
  • Alpha beta antagonist therapy
  • Supplemental cortisol
  • General anesthesia preferred over regional
  • Blood pressure control
  • (Nitroprusside, Phenylephrine)
  • Control of cardiac rate rhythm
  • (Esmolol, Lidocaine)
  • Neuraxial opioids

43
Pheochromocytoma Monitoring
  • Pulmonary artery catheter
  • Balance Electrolyte Status
  • Glucose determinations
  • Arterial catheterization

44
Hepatic Disease
45
Liver Disease History
  • Jaundice
  • Gastrointestinal bleeding
  • Untoward effects of prior anesthetics
  • Decreased exercise tolerance

46
Physical Findings
  • Hepatosplenomegaly
  • Arteriovenous fistulas (spider nevi)
  • Ascites
  • Cardiomyopathy
  • Encephalopathy

47
Hepatic Laboratory Findings
  • Abnormal liver function tests
  • Coagulopathy (PT, PTT increased)
  • Thrombocytopenia
  • Renal dysfunction (hypernatremia)

48
Changes in Hepatic Cirrhosis
  • Increased pulmonary shunting
  • Renal dysfunction (sodium retention)
  • Ascites and edema
  • Anemia, thrombocytopenia

49
Changes in Hepatic Cirrhosis
  • Decreased clotting factors
  • (II, VII, IX, X)
  • Hypoalbuminemia
  • Hepatorenal syndrome
  • Encephalopathy

50
Differential Diagnosisof Hepatic Dysfunction
51
Bilirubin Overload (Hemolysis)
  • Unconjugated
  • Normal
  • Normal
  • Normal
  • Normal
  • Bilirubin
  • Aminotransferases
  • Alkaline phosphatase
  • Prothrombin time
  • Serum proteins

52
Hepatocellular Dysfunction
  • Conjugated
  • Increased
  • Normal
  • Prolonged
  • Decreased
  • Bilirubin
  • Aminotransferases
  • Alkaline phosphatase
  • Prothrombin time
  • Serum proteins

53
Causes of Postoperative Hepatic Necrosis
  • Hypoxemia
  • Ischemia
  • Sepsis
  • Viral Infection
  • Pre-existing liver disease
  • Drugs

54
Cardiovascular Changes Hepatic Cirrhosis
  • Hyperdynamic circulation
  • Increased cardiac output
  • Decreased peripheral resistance
  • Increased blood volume
  • Arteriovenous fistulas

55
Cardiovascular Changes Hepatic Cirrhosis
  • Decreased hepatic blood flow
  • Portal hypertension
  • Decreased arterial flow
  • Cardiomyopathy

56
Liver Disease Risk Factors
  • Bilirubin gt 3 mg/dl
  • Albumin lt 3 g/dl
  • Prothrombin time (seconds
  • prolonged) gt 6
  • Poor nutritional state
  • Ascites
  • Encephalopathy

57
Preanesthetic Treatment(Liver Disease)
  • Correct coagulation defects
  • (vitamin K)
  • Correct hypoalbuminemia
  • Reduce edema
  • (furosemide, mannitol)

58
Liver Disease Jaundice
  • Bilirubin overload
  • (hemolysis from blood, hematoma)
  • Cholestasis
  • Intrahepatic (infection, drug-induced)
  • Extrahepatic (bile duct injury, gallstones)

59
Liver Disease Jaundice
  • Hepatocellular injury
  • Hypoxia or ischemia
  • Drug-induced
  • Exacerbation of pre-existing disease (stress)
  • Viral hepatitis

60
Conditions that Lower Esophageal Sphincter Tone
  • Obesity
  • Pregnancy
  • Hiatal hernia
  • Reflux syndromes

61
Drugs that Decrease Esophageal Sphincter Tone
  • Anticholinergics
  • Opioids
  • Volatile anesthetics
  • Intravenous anesthetics

62
Drugs that Increase Esophageal Sphincter Tone
  • Anticholinesterases
  • Succinylcholine
  • Metoclopramide

63
Causes of Upper GI Bleeding
  • Incidence ()
  • 27
  • 23
  • 14
  • 13
  • Duodenal ulcer
  • Gastritis
  • Varices
  • Esophagitis

64
Causes of Upper GI Bleeding
  • Incidence ()
  • 8
  • 7
  • 3
  • 5
  • Gastric ulcer
  • Mallory-Weiss tear
  • Bowel infarction
  • Idiopathic

65
Reducing Risk of Aspiration
  • Nasogastric suction
  • Metoclopramide
  • H2 antagonists

66
Reducing Risk of Aspiration
  • Nonparticulate antacids (Sucralfate)
  • Awake intubation
  • Rapid sequence induction-cricoid pressure

67
Acute Pancreatitis Predisposing Conditions
  • Alcohol abuse
  • Gallstones
  • Blunt abdominal trauma
  • Penetrating peptic ulcer
  • Cardiopulmonary bypass

68
Cholestasis
  • Conjugated
  • May be increased
  • Increased
  • May be prolonged
  • May be increased
  • Bilirubin
  • Aminotransferases
  • Alkaline phosphatase
  • Prothrombin time
  • Serum proteins

69
Laparoscopic Cholecystectomy
  • Risk Factors
  • Impaired venous return
  • Carbon dioxide embolism
  • Underventilation
  • Gastric reflux (decompression desirable)
  • Loss of hemostasis, requiring laparotomy

70
Open Cholecystectomy
  • Risk factors
  • Biliary spasm (opioids-Morphine? )
  • Postoperative pain

71
Carcinoid Syndrome
72
Carcinoid Syndrome
  • Cutaneous flushing
  • Labile blood pressure
  • Diarrhea
  • Bronchospasm
  • Cardiac failure (cardiomyopathy)

73
Carcinoid Treatment
  • Fluid resuscitation
  • H1 and H2 antagonists
  • Serontonin (5-HT) antagonists
  • Bronchodilators
  • Vasoactive drugs
  • Octreotide
Write a Comment
User Comments (0)
About PowerShow.com